Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold

被引:52
作者
Cheng, MY
De, B
Almstead, NG
Pikul, S
Dowty, ME
Dietsch, CR
Dunaway, CM
Gu, F
Hsieh, LC
Janusz, MJ
Taiwo, YO
Natchus, MG
Hudlicky, T
Mandel, M
机构
[1] Procter & Gamble Co, Mason, OH 45040 USA
[2] Univ Florida, Dept Chem, Gainesville, FL 32611 USA
关键词
D O I
10.1021/jm9904699
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and structure-activity relationship (SAR) studies of a series of proline-based matrix metalloproteinase inhibitors are described. The data reveal a remarkable potency enhancement in those compounds that contain an sp(2) center at the C-4 carbon of the ring relative to similar, saturated compounds. This effect was noted in compounds that contained a functionalized oxime moiety or an exomethylene at C-4, and the potencies were typically <10 nM for MMP-3 and <100 nM for MMP-1. Comparisons were then made against compounds with similar functionality where the C-4 carbon was reduced to sp(3) hybridization and the effect was typically an order of magnitude loss in potency. A comparison of compounds 14 and 34 exemplifies this observation. An X-ray structure was obtained for a stromelysin-inhibitor complex which provided insights into the SAR and selectivity trends observed within the series. In vitro intestinal permeability data for many compounds was also accumulated.
引用
收藏
页码:5426 / 5436
页数:11
相关论文
共 41 条
[21]  
Hauser C. R., 1943, ORG SYNTH, V2, P67
[22]   SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN THE LEWIS RAT BY THE MATRIX METALLOPROTEINASE INHIBITOR RO31-9790 [J].
HEWSON, AK ;
SMITH, T ;
LEONARD, JP ;
CUZNER, ML .
INFLAMMATION RESEARCH, 1995, 44 (08) :345-349
[23]   SYSTEM ORIENTED DESIGN OF TRIQUINANES - STEREOCONTROLLED SYNTHESIS OF PENTALENIC ACID AND PENTALENENE [J].
HUDLICKY, T ;
SINAIZINGDE, G ;
NATCHUS, MG ;
RANU, BC ;
PAPADOPOLOUS, P .
TETRAHEDRON, 1987, 43 (23) :5685-5721
[24]   A NOVEL COUMARIN-LABELED PEPTIDE FOR SENSITIVE CONTINUOUS ASSAYS OF THE MATRIX METALLOPROTEINASES [J].
KNIGHT, CG ;
WILLENBROCK, F ;
MURPHY, G .
FEBS LETTERS, 1992, 296 (03) :263-266
[25]  
LaFleur M, 1996, J EXP MED, V184, P2311
[26]   Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits [J].
MacPherson, LJ ;
Bayburt, EK ;
Capparelli, MP ;
Carroll, BJ ;
Goldstein, R ;
Justice, MR ;
Zhu, LJ ;
Hu, SI ;
Melton, RA ;
Fryer, L ;
Goldberg, RL ;
Doughty, JR ;
Spirito, S ;
Blancuzzi, V ;
Wilson, D ;
OByrne, EM ;
Ganu, V ;
Parker, DT .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (16) :2525-2532
[27]  
MACPHERSON LJ, 1993, Patent No. 0606046
[28]   Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions [J].
Maeda, A ;
Sobel, RA .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (03) :300-309
[29]  
MUZARD M, 1992, SYNTHESIS-STUTTGART, P965
[30]   Design and synthesis of conformationally-constrained MMP inhibitors [J].
Natchus, MG ;
Cheng, MY ;
Wahl, CT ;
Pikul, S ;
Almstead, NG ;
Bradley, RS ;
Taiwo, YO ;
Mieling, GE ;
Dunaway, CM ;
Snider, CE ;
McIver, JM ;
Barnett, BL ;
McPhail, SJ ;
Anastasio, MB ;
De, B .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (16) :2077-2080